JAN 12, 2016 9:20 AM PST

Nisin ‘milkshake' kills cancer cells in mice

Nisin, a naturally occurring preservative found in many foods, is showing promise as a way to fight cancer and antibiotic-resistant bacteria.

Feeding rats a high-dose “nisin milkshake” killed 70 to 80 percent of head and neck tumor cells after nine weeks and extended survival, says Yvonne Kapila, professor at the University of Michigan School of Dentistry.
 
"Mother Nature has done a lot of the research for us-it's been tested for thousands of years," says Yvonne Kapila.

The dosage of 800 mg/kg given to mice would translate to a pill a little bigger than a third of an Advil per kilogram of body weight for people.

While promising, it’s too early to say if nisin will act the same way in humans, Kapila says.

Nisin also fights deadly bacteria such as antibiotic-resistant MRSA. In a recent review paper, Kapila’s group looked at experimental uses of nisin to treat 30 different types of cancer; infections of the skin, respiratory system, and abdomen; and oral health problems.

“To date, nobody has found bacteria from humans or living animals that are resistant to nisin,” Kapila says.

Two things make nisin lethal to bacteria: It binds to a static area of bacteria, which gives it the opportunity to work before bacteria changes into an antibiotic-resistant superbug, and it kills biofilms—colonies of bacteria that group together into a fortress that thwarts antibiotics.

Another positive is that nisin has withstood the test of time, Kapila says. “Mother Nature has done a lot of the research for us—it’s been tested for thousands of years.”

The next step will be to test it in in a clinic setting.

“The application of nisin has advanced beyond its role as a food biopreservative,” Kapila says. “Current findings and other published data support nisin’s potential use to treat antibiotic-resistant infections, periodontal disease, and cancer."

The findings appear in the Journal of Antimicrobial Chemotherapy.

This article was originally published on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
APR 21, 2021
Cancer
Native shrub could fight undruggable cancer gene
APR 21, 2021
Native shrub could fight undruggable cancer gene
New research published in the Journal of the American Chemical Society reports on another cancer-fighting development, t ...
JUN 12, 2021
Cancer
Using astronomy to image cancer tumors
JUN 12, 2021
Using astronomy to image cancer tumors
In an interdisciplinary breakthrough, a recent study published in Science describes the development of a new platform, d ...
JUN 27, 2021
Cancer
Are e-cigarettes actually helpful for smoking cessation?
JUN 27, 2021
Are e-cigarettes actually helpful for smoking cessation?
New research published in The Lancet Public Health reports on a study that looked at interventions targeting e-cigarette ...
JUL 08, 2021
Genetics & Genomics
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
JUL 08, 2021
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
Children with Down syndrome have a significantly higher likelihood myeloid leukemia occurring in the first five years of ...
JUL 13, 2021
Clinical & Molecular DX
Friend or Foe? New Cancer-Tracking Pen Guides Surgeons.
JUL 13, 2021
Friend or Foe? New Cancer-Tracking Pen Guides Surgeons.
Researchers have developed the first diagnostic “pen” that acts as a guide for surgeons, helping them distin ...
JUL 23, 2021
Cancer
Repurposed Antibiotics Show Promise Against Skin Cancer
JUL 23, 2021
Repurposed Antibiotics Show Promise Against Skin Cancer
In experiments with mice, researchers from the Netherlands have found that some antibiotics may be effective in tre ...
Loading Comments...